Clal Insurance’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $3.11M | Sell |
|
|||||
|
2023
Q2 | $5.48M | Hold |
|
|||||
|
2023
Q1 | $4.89M | Hold |
|
|||||
|
2022
Q4 | $4.7M | Hold |
|
|||||
|
2022
Q3 | $4.41M | Hold |
|
|||||
|
2022
Q2 | $4.34M | Hold |
|
|||||
|
2022
Q1 | $4.61M | Hold |
|
|||||
|
2021
Q4 | $5.03M | Hold |
|
|||||
|
2021
Q3 | $8.9M | Hold |
|
|||||
|
2021
Q2 | $8.08M | Hold |
|
|||||
|
2021
Q1 | $10.3M | Hold |
|
|||||
|
2020
Q4 | $8.91M | Hold |
|
|||||
|
2020
Q3 | $10.2M | Hold |
|
|||||
|
2020
Q2 | $13.8M | Hold |
|
|||||
|
2020
Q1 | $9.44M | Buy |
|
|||||
|
2019
Q4 | $529K | Sell |
|
|||||
|
2019
Q3 | $12.6M | Sell |
|
|||||
|
2019
Q2 | $19.9M | Sell |
|
|||||
|
2019
Q1 | $20.5M | Buy |
|
|||||
|
2018
Q4 | $17.2M | Buy |
|
|||||
|
2018
Q3 | $14.6M | Hold |
|
|||||
|
2018
Q2 | $15.4M | Buy |
|
|||||
|
2018
Q1 | $14.1M | Buy |
|
|||||
|
2017
Q4 | $166K | Buy |
|